TherapeuticsMD, Inc.
General ticker "TXMD" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $13.1M (TTM average)
TherapeuticsMD, Inc. follows the US Stock Market performance with the rate: 31.9%.
Estimated limits based on current volatility of 2.4%: low 2.05$, high 2.16$
Factors to consider:
- Total employees count: 5 as of 1995
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.09$, 2.32$]
- 2026-12-31 to 2027-12-31 estimated range: [0.96$, 2.08$]
Financial Metrics affecting the TXMD estimates:
- Positive: with PPE of -32.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Positive: 6.68 < Operating cash flow per share per price, % of 12.66
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: Shareholder equity ratio, % of 71.37 > 64.25
- Positive: -3.36 < Return on assets ratio (scaled to [-100,100]) of -1.49
Short-term TXMD quotes
Long-term TXMD plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $1.76MM | $3.02MM |
| Operating Expenses | $6.52MM | $7.24MM |
| Operating Income | $-4.76MM | $-4.21MM |
| Non-Operating Income | $2.42MM | $3.56MM |
| Interest Expense | $0.01MM | $0.00MM |
| Income(Loss) | $-2.34MM | $-0.65MM |
| Taxes | $-0.03MM | $-0.08MM |
| Profit(Loss)* | $-2.18MM | $-0.57MM |
| Stockholders Equity | $27.37MM | $26.88MM |
| Assets | $38.82MM | $37.66MM |
| Operating Cash Flow | $0.73MM | $2.45MM |
| Earnings Per Share** | $-0.19 | $-0.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.